Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05886218 · ClinicalTrials.gov registry record
Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery
A clinical trial of Sugammadex, sponsored by University of California, Davis.
- Recruiting
- Registry status
- 215
- Enrollment target
- 1
- Study location
NCT05886218 is a study of Sugammadex that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 215 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05886218, a study of Sugammadex, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- 215 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.
Conditions Studied
Interventions
- DEVICE Quantitative Neuromuscular Function Monitoring
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2023-02-08 |
| Est. Completion | 2025-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05886218
The ClinicalTrials.gov registry entry for NCT05886218 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sugammadex appearing as the primary indexed condition, and to 1 intervention - of which Quantitative Neuromuscular Function Monitoring is the first listed.
NCT05886218 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05886218 about?
NCT05886218 is a clinical study titled "Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery". This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.
What is the current status of trial NCT05886218?
This trial is currently recruiting. The enrollment target is 215 participants. The study started on 2023-02-08. Estimated completion is 2025-07.
What conditions does trial NCT05886218 study?
This clinical trial studies the following conditions: Sugammadex.
What interventions are being tested in trial NCT05886218?
The interventions under investigation include: Quantitative Neuromuscular Function Monitoring (DEVICE).
Who is sponsoring clinical trial NCT05886218?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05886218 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sugammadex
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.